257 related articles for article (PubMed ID: 11224996)
21. Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm.
Pennathur A; Luketich JD; Landreneau RJ; Ward J; Christie NA; Gibson MK; Schuchert M; Cooper K; Land SR; Belani CP
Ann Thorac Surg; 2008 Jun; 85(6):1930-6; discussion 1936-7. PubMed ID: 18498797
[TBL] [Abstract][Full Text] [Related]
22. [Concomitant chemoradiotherapy of cancer of the esophagus].
Calais G
Cancer Radiother; 1998 Dec; 2(6):689-95. PubMed ID: 9922774
[TBL] [Abstract][Full Text] [Related]
23. Preoperative chemoradiotherapy in cancer of the thoracic esophagus.
Terrosu G; Cedolini C; Bresadola V; Baccarani U; Uzzau A; Signor M; Fongione S; Buffoli A; Iop A; Vigevani E; Sacco C; Cartei G; Bresadola F
Dis Esophagus; 2003; 16(1):9-16. PubMed ID: 12581248
[TBL] [Abstract][Full Text] [Related]
24. [Preoperative chemoradiation in esophageal cancer: experience of a single center in 102 patients].
Imdahl A; Schöffel U; Ruf G; Hopf UT
Zentralbl Chir; 2004 Oct; 129(5):350-5. PubMed ID: 15486784
[TBL] [Abstract][Full Text] [Related]
25. A comparative longitudinal quality of life study using the Spitzer quality of life index in a randomized multicenter phase III trial (FFCD 9102): chemoradiation followed by surgery compared with chemoradiation alone in locally advanced squamous resectable thoracic esophageal cancer.
Bonnetain F; Bouché O; Michel P; Mariette C; Conroy T; Pezet D; Roullet B; Seitz JF; Paillot B; Arveux P; Milan C; Bedenne L
Ann Oncol; 2006 May; 17(5):827-34. PubMed ID: 16524973
[TBL] [Abstract][Full Text] [Related]
26. Induction therapy does not increase surgical morbidity after esophagectomy for cancer.
Lin FC; Durkin AE; Ferguson MK
Ann Thorac Surg; 2004 Nov; 78(5):1783-9. PubMed ID: 15511475
[TBL] [Abstract][Full Text] [Related]
27. Surgical resection with and without chemotherapy in oesophageal cancer.
Maraveyas A; O'Boyle C; Cowen M
Lancet; 2002 Oct; 360(9340):1174-5; author reply 1175. PubMed ID: 12387981
[No Abstract] [Full Text] [Related]
28. Phase II evaluation of preoperative chemoradiation and postoperative adjuvant chemotherapy for squamous cell and adenocarcinoma of the esophagus.
Heath EI; Burtness BA; Heitmiller RF; Salem R; Kleinberg L; Knisely JP; Yang SC; Talamini MA; Kaufman HS; Canto MI; Topazian M; Wu TT; Olukayode K; Forastiere AA
J Clin Oncol; 2000 Feb; 18(4):868-76. PubMed ID: 10673530
[TBL] [Abstract][Full Text] [Related]
29. Preoperative chemotherapy with cisplatin and docetaxel followed by surgery and clip-oriented postoperative chemoradiation in patients with localized gastric or gastroesophageal junction adenocarcinoma: results from a phase II feasibility study.
Spizzo G; Öfner D; de Vries A; Lukas P; Steger G; Pluschnig U; Zacherl J; Widder J; Zabernigg A; Gastl G; Mühlmann G
Ann Surg Oncol; 2011 Mar; 18(3):677-83. PubMed ID: 21063792
[TBL] [Abstract][Full Text] [Related]
30. Improved outcomes in the management of esophageal cancer with the addition of surgical resection to chemoradiation therapy.
McKenzie S; Mailey B; Artinyan A; Metchikian M; Shibata S; Kernstine K; Kim J
Ann Surg Oncol; 2011 Feb; 18(2):551-8. PubMed ID: 20839062
[TBL] [Abstract][Full Text] [Related]
31. Multimodality treatment in the management of esophageal cancer: neoadjuvant chemoradiotherapy followed by transhiatal esophagectomy.
Irwin JF; Waterfield W; Poussin-Rosillo H; Sardi A
Md Med J; 1997 Oct; 46(9):471-76. PubMed ID: 9327648
[TBL] [Abstract][Full Text] [Related]
32. [Changes and complication rate in surgery for thoracic esophageal carcinoma].
Meyer T; Merkel S; Göhl J; Stumpf P; Hohenberger W
Zentralbl Chir; 2003 Aug; 128(8):631-9. PubMed ID: 12931257
[TBL] [Abstract][Full Text] [Related]
33. Carcinoma of the esophagus.
Parker EF; Gregorie HB; Arrants JE; Ravenel JM
Ann Surg; 1970 May; 171(5):746-51. PubMed ID: 4192275
[No Abstract] [Full Text] [Related]
34. [Radiotherapy of esophageal cancer in combination with chemotherapy].
Jinnouchi S; Koga K; Nishikawa K; Kihara Y; Kusuhara T; Watanabe K
Nihon Igaku Hoshasen Gakkai Zasshi; 1983 Nov; 43(11):1278-83. PubMed ID: 6672755
[No Abstract] [Full Text] [Related]
35. Primary chemo-radiotherapy and selective oesophagectomy for oesophageal cancer: goal of cure with organ preservation.
Wilson KS; Lim JT
Radiother Oncol; 2000 Feb; 54(2):129-34. PubMed ID: 10699475
[TBL] [Abstract][Full Text] [Related]
36. Resectable esophageal carcinoma: local control with neoadjuvant chemotherapy and radiation therapy.
Chidel MA; Rice TW; Adelstein DJ; Kupelian PA; Suh JH; Becker M
Radiology; 1999 Oct; 213(1):67-72. PubMed ID: 10540642
[TBL] [Abstract][Full Text] [Related]
37. Defining cure for esophageal cancer: analysis of actual 5-year survivors following esophagectomy.
Hirst J; Smithers BM; Gotley DC; Thomas J; Barbour A
Ann Surg Oncol; 2011 Jun; 18(6):1766-74. PubMed ID: 21213056
[TBL] [Abstract][Full Text] [Related]
38. [Principles of neoadjuvant therapy].
Lordick F
Chirurg; 2009 Nov; 80(11):1000-5. PubMed ID: 19812908
[TBL] [Abstract][Full Text] [Related]
39. Esophageal carcinoma with doubtful extirpability. Value of preoperative chemotherapy plus radiotherapy.
Sielezneff I; Thomas P; Giovannini M; Guidicelli R; Seitz JF; Fuentes P
Eur J Cardiothorac Surg; 1993; 7(11):606-11. PubMed ID: 8297615
[TBL] [Abstract][Full Text] [Related]
40. Phase II study of preoperative paclitaxel/cisplatin with radiotherapy in locally advanced esophageal cancer.
Kim DW; Blanke CD; Wu H; Shyr Y; Berlin J; Beauchamp RD; Chakravarthy B
Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):397-404. PubMed ID: 17097833
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]